Northpointe Capital’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-163,324
| Closed | -$7.41M | – | 199 |
|
|
2017
Q1 | $7.41M | Sell |
163,324
-42,199
| -21% | -$1.91M | 0.81% | 41 |
|
|
2016
Q4 | $7.78M | Sell |
205,523
-70,191
| -25% | -$2.66M | 0.77% | 44 |
|
|
2016
Q3 | $10.4M | Sell |
275,714
-206,055
| -43% | -$7.78M | 1.08% | 27 |
|
|
2016
Q2 | $8.48M | Buy |
481,769
+189,629
| +65% | +$3.34M | 1% | 32 |
|
|
2016
Q1 | $3.55M | Sell |
292,140
-150,985
| -34% | -$1.84M | 0.44% | 83 |
|
|
2015
Q4 | $7.86M | Hold |
443,125
| – | – | 1.03% | 26 |
|
|
2015
Q3 | $7.86M | Sell |
443,125
-591,275
| -57% | -$10.5M | 1.02% | 26 |
|
|
2015
Q2 | $18.3M | Buy |
1,034,400
+706,488
| +215% | +$12.5M | 2.15% | 2 |
|
|
2015
Q1 | $10.3M | Buy |
+327,912
| New | +$10.3M | 1.11% | 22 |
|